Regeneron Pharmaceuticals (REGN)
R&D Expense Growth
-0.84%
Quarterly · Period ending:
REGN R&D Expense Growth
Latest reported-0.84%period ending
Latest reported-0.84%period ending
REGN Quarterly R&D Growth (QoQ) (0.00% → -0.84%)
Latest values, visible window
High-resolution chart · PNG
REGN r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -0.8387% | |
| 1.1869% | |
| 4.3643% | |
| 8.8287% | |
| 6.8672% | |
| -6.0453% | |
| 7.3962% | |
| 8.4811% | |
| -2.5169% | |
| 19.5031% | |
| 8.3204% | |
| -1.2523% | |
| -1.9467% | |
| 6.3828% | |
| 15.0116% | |
| 13.7241% | |
| -6.4457% | |
| 8.2126% | |
| 20.0777% | |
| -7.9148% | |
| -4.7964% | |
| -1.0691% | |
| 9.1956% | |
| -5.7147% | |
| 25.6537% | |
| -22.7346% | |
| 44.3881% | |
| -43.2325% | |
| 91.5422% | |
| -22.0867% | |
| 7.0772% | |
| 5.2223% | |
| 7.23% | |
| -6.3322% | |
| 0.2939% | |
| 3.6182% | |
| 1.1781% | |
| 4.2225% | |
| -12.5972% | |
| -7.9871% | |
| 19.1057% | |
| 1.9301% | |
| 8.2846% | |
| 9.119% | |
| 13.7614% | |
| -2.4541% | |
| 4.1504% | |
| 14.678% | |
| 2.4783% | |
| 7.175% | |
| 19.6813% | |
| 19.5143% | |
| 3.9734% | |
| -0.4005% | |
| 14.3586% | |
| 7.4111% | |
| 6.1291% | |
| 7.6108% | |
| 0.8732% | |
| -10.6358% | |
| 10.632% | |
| 3.3383% | |
| 2.5966% | |
| -1.994% | |
| 6.0057% | |
| -1.1104% | |
| 12.6676% | |
| 11.8889% | |
| 14.7116% | |
| 7.6421% | |
| 3.3295% | |
| 10.9317% | |
| 8.6617% | |
| -5.484% | |
| 25.4135% | |
| 17.8392% | |
| 6.3757% | |
| 15.2653% | |
| 2.7752% | |
| 1.1919% | |
| 7.2123% | |
| -15.3702% | |
| -7.795% | |
| 1.1663% | |
| 13.1711% | |
| 3.228% | |
| 5.9736% | |
| -9.5573% | |
| 12.7902% | |
| -3.2645% | |
| -3.9913% | |
| 2.7672% | |
| -1.957% | |
| -0.1887% | |
| 0.4695% | |
| 11.6996% | |
| 20.5182% | |
| -15.3654% | |
| 20.2125% | |
| 27.7761% |